Resource usage in outpatient care and reimbursement for cystic fibrosis in Germany

Pediatric Pulmonology

Volumn 46, Issue 3, 2011, Pages 278-285

  Eidt Koch, Daniela ^a   Wagner, Thomas O F ^b   Mittendorf, Thomas ^c,d   Reimann, Andreas ^e   Von Der Schulenburg, J Matthias ^c  

^a OSTFALIA UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^d Herescon GmbH Health Economic Research and Consulting   (Germany)

^e Mukoviszidose eV   (Germany)

Author keywords

Cost analysis; Cystic fibrosis; Germany; Reimbursement

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; CHILD; COST BENEFIT ANALYSIS; CYSTIC FIBROSIS; DEMOGRAPHY; FEMALE; GERMANY; HEALTH CARE SYSTEM; HEPATOBILIARY DISEASE; HUMAN; INFANT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT CARE; PANCREAS INSUFFICIENCY; PRESCHOOL CHILD; PRIORITY JOURNAL; REIMBURSEMENT; REMUNERATION; RESOURCE MANAGEMENT; SCHOOL CHILD; SOCIAL ASPECT; AMBULATORY CARE; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; ECONOMICS; HEALTH CARE PLANNING; UTILIZATION; YOUNG ADULT;

ADOLESCENT; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; GERMANY; HEALTH RESOURCES; HUMANS; INFANT; MALE; REIMBURSEMENT MECHANISMS; YOUNG ADULT;

EID: 79951801790     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21364     Document Type: Article

References (16)

1. Stern M, Sens B, Wiedemann B, Busse O, Damm G, Wenzlaff P, editors. Qualitätssicherung Mukoviszidose-Überblick über den Gesundheitszustand der Patienten in Deutschland 2007. Bad Honnef: Hippocampus Verlag; 2009.
2. German Cystic Fibrosis Patient Advacacy Group. Internal Member Surveys, Personal communication, Data on file, 2008.
3. Eidt-Koch D, Wagner TOF, Mittendorf T, Schulenburg JM. Outpatient medication costs of patients with cystic fibrosis in Germany. Appl Health Econ Health Policy Decis 2010;8:111-118.
4. Kerem E, Conway S, Elborn S, Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005;4:7-26. (Pubitemid 40347773)
5. Krauth C, Jalilvand N, Welte T, Busse R. Cystic fibrosis-cost of illness and considerations for the economic evaluation of potential therapies. Pharmacoeconomics 2003;14:1001-1024. (Pubitemid 37255455)
6. Ireys H, Anderson G, Shaffer T, Neff JM. Expenditures for care of children with chronic illnesses enrolled in Washington State Medicaid Program, fiscal year 1993. Pediatrics 1997;100:197-204. (Pubitemid 27328196)
7. Johnson JA, Connolly MA, Jacobs P, Montgomery M, Brown NE, Zuberbuhler P. Cost of care for individuals with cystic fibrosis: a regression approach to determining the impact of recombinant human DNase. Pharmacotherapy 1999;19:1159-1166. (Pubitemid 29455937)
8. Lieu TA, Ray GT, Farmer G, Shay GF. The cost of medical care for patients with cystic fibrosis in a health maintenance organization. Pediatrics 1999;103:e72.
9. Pauly MV. The economics of cystic fibrosis. In: Lloyd-Still JD, editor. Textbook of cystic fibrosis. Boston: John Wright PSG Inc; 1983. pp. 465-476.
10. Robson M, Abbott J, Webb K, Dodd M, Walsworth-Bell J. A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients. Thorax 1992;47:684-689.
11. Schreyögg J, Hollmeyer H, Bluemel M, Staab D, Busse R. Hospitalisation costs of cystic fibrosis. Pharmacoeconomics 2006;10:999-1009. (Pubitemid 44497471)
12. Wildhagen MF, Verheij JB, Hilderink HBM, Kooij L, Tijmstra T, ten Kate LP, Gerritsen J, Bakker W, Habbema JDF. Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1. Thorax 1996;51:298-301.
13. Wildhagen MF, Verheij JBGM, Verzijl JG, Gerritsen J, Bakker W, Hilderink HBM, Ten kate LP, Tijmstra T, Kooij L, Habbema JDF. The nonhospital costs of care of patients with CF in the Netherlands: results of a questionnaire. Eur Resp J 1996;9:2215-2219.
14. Baumann U, Stocklossa C, Greiner W. Cost of care and clinical condition in paediatric cystic fibrosis patients. J Cyst Fibros 2003;2:84-90. (Pubitemid 36814095)
15. Huscher D, Merkesdal S, Thiele K, et al. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systematic lupus erythematosus in Germany. Ann Rheum Dis 2006;65:1175-1183. (Pubitemid 44277392)
16. Ruof J, Hülsemann JL, Mittendorf T, et al. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources. Ann Rheum Dis 2003;62:544-550. (Pubitemid 36606288)